Finance

Endovascular device company reports Q4 2005 net sales up 60% to $41 million over year ago

Published in Blood Weekly, March 23rd, 2006

Ev3 Inc. (EVVV), an endovascular device company, reported in financial results for the fiscal fourth quarter and fiscal year ended December 31, 2005 net sales of $41 million, an increase of 60% versus net sales of $25.5 million in the fourth quarter of 2004.

This growth was broad-based and generated internally, reflecting strong sales growth from domestic and international markets, as well as from both ev3's cardio peripheral and neurovascular business segments.

For the fiscal year ended December 31, 2005, ev3's net sales were $133.7 million, an increase of 55% over net sales for fiscal 2004 of $86.3 million. Annual sales growth in 2005 also was...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2006-03-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry